| | | Experimental group | Control group |
| | CXQ + WM vs. WM | 5/89 cases: dizziness, 1 case; hypersomnia, 1 case; dry mouth, 3 cases | 0/81 cases |
| | DS + WM vs. WM | 1/90 cases: skin rash, 1 case | 0/90 cases |
| | DSCX + WM vs. WM | 3/123 cases: gastrointestinal adverse reactions, 3 cases | 4/123 cases: gastrointestinal adverse reactions, 2 cases; liver dysfunction, 2 cases |
| | DH + WM vs. FFDS + WM | 0/60 cases | 0/60 cases |
| | DZH + WM vs. WM | 0/60 cases | 1/60 cases: bleeding, 1 case |
| | HQ + WM vs. WM | 18/84 cases Acne, 3 cases; hirsutism, 2 cases; alopecia, 1 case; insomnia, 5 cases; infections, 6 cases; vomiting, 1 case | 19/84 cases: acne, 4 cases; hirsutism, 3 cases; alopecia, 4 cases; insomnia, 4 cases; infections, 3 cases; gastrointestinal adverse reaction, 1 case |
| | SK + WM vs. DS + WM | 0/50 cases | 0/50 cases |
| | SK + WM vs. WM | 2/61 cases: headache, 2 cases | 0/62 cases |
| | SXT + WM vs. FFDS + WM | 0/60 cases | 0/60 cases |
| | SXT + WM vs. WM | 2/55 cases: subcutaneous haemorrhage, 2 cases | 0/55 cases |
| | YXY + WM vs. WM | 4/68 cases: gastrointestinal adverse reactions, 2 cases; elevated blood pressure, 2 cases | 10/68 cases: gastrointestinal adverse reactions, 7 cases; elevated blood pressure, 3 cases |
| | YXY + WM vs. FFDS + WM | 0/30 cases | 0/30 cases |
| | XST + WM vs. DZH + WM | 7/28 cases: subcutaneous haemorrhage, 6 cases; non-specific adverse reaction, 1 case | 4/28 cases: subcutaneous haemorrhage, 4 cases |
|
|
WM = Western medicine, CXQ = Chuanxiongqin injection, DS = Danshen injection, DSCX = Danshenchuanxiongqin injection, DH = Danhong injection, DZH = Dengzhanhua injection, FFDS = Fufangdanshen injection, HQ = Huangqi injection, SK = Shenkang injection, SXT = Shuxuetong injection, YXY = Yinxingye injection, and XST = Xueshuantong injection.
|
